UMass, Sepragen and the University of Pennsylvania will create a continuous, automated, compact mRNA producing machine.
To do this, the team will:
All these tasks at the conclusion of the project will be integrated to successfully produce continuous purification platform for Mab production.
Login to the NIIMBL member portal to access more, including:
Not yet a member? Learn more about which level of NIIMBL membership is right for you and your organization.
University of Massachusetts System
Sepragen Corporation